
Gyroscope Therapeutics raises $148m in Forbion-led series C
Gyroscope Therapeutics, a London-based clinical-stage gene therapy company, has secured $148m in a series-C financing round led by Forbion’s Growth Opportunities Fund.
Latest News
Essling founder sells business to private investors
Frank-Noël Vandenberghe exits the business he co-founded with Michele Mezzarobba, who left last year
Aurelius raises first fund for institutional investors
Investor's €360m fund has an extra capacity of €150m from the GP's listed vehicle and will focus on carve-outs
Brightlands Venture Partners IV holds €45m first close
Fund invests in renewable chemistry, regenerative medicine and agri-food across the Netherlands, Belgium and parts of Germany
Battery Ventures buys IMC Test & Measurement
Company will operate with the GP's existing test and measurement companies in the US and Denmark
Back to Top